2. Academic Validation
  3. Structural and Molecular Insight into the PWWP1 Domain of NSD2 from the Discovery of Novel Binders Via DNA-Encoded Library Screening

Structural and Molecular Insight into the PWWP1 Domain of NSD2 from the Discovery of Novel Binders Via DNA-Encoded Library Screening

  • ACS Med Chem Lett. 2025 Aug 25;16(9):1703-1708. doi: 10.1021/acsmedchemlett.5c00396.
Gavin W Collie 1,  Bryony Ackroyd 1,  Catriona Corbishley 1,  Daniel H O'Donovan 2,  Alex Edwards 1,  Andrea Gohlke 1,  Xiaoxiao Guo 1,  Bethan Howells 1,  Yuliang Li 3,  Andrew Madin 1,  Alexander G Milbradt 1,  Emma L Rivers 1,  Sandeep K Talapatra 1,  Elizabeth Underwood 1,  Alice Webb 1
Affiliations

Affiliations

  • 1 Discovery Sciences, R&D, AstraZeneca, Cambridge CB2 0AA, U.K.
  • 2 Oncology R&D , AstraZeneca, Cambridge CB2 0AA, U.K.
  • 3 Pharmaron Beijing Co., Ltd., Beijing 100176, P.R. China.
PMID: 40959233 DOI: 10.1021/acsmedchemlett.5c00396
Abstract

NSD2 is a key epigenetic regulator and has received considerable attention as a drug target due to its well-documented role in tumorigenesis. We report here a DNA-encoded library screen targeting the PWWP1 domain of NSD2 from which we discovered novel, potent, and selective Binders. Furthermore, these compounds were used to develop a novel crystal system, increasing our understanding of the folding of this domain. Together, these results provide a solid molecular and structural basis for the further study of the PWWP1 domain of NSD2 as a Cancer drug target.

Keywords

DEL; NSD2; PWWP1; drug discovery; encoded library.

Figures
Products